From the edition of October 1, 2026 Warm, curious, carefully sourced takes on the day's most interesting stories. Translate
Science · Related read

4 warning signs doctors track to catch multiple myeloma

Unexplained rib fractures often point back to four classic clinical markers known as the CRAB criteria. Here is what blood tests, marrow biopsies and imaging look for.

Four neatly arranged botanical glass beakers and an open diagnostic ledger on a sun-drenched wooden desk.
Four quiet diagnostic clues help clinicians see beneath unexplained aches and spot cell changes early. Illustration: Joyful Take.

When an adult develops unexplained bone pain or persistent exhaustion, primary care physicians and hematologists do not guess in the dark. Instead, they rely on a universally recognized diagnostic framework known as the CRAB criteria. This four-letter medical acronym summarizes the primary organ damage markers caused by proliferating plasma cells.

When I examined how Charles Kelley's unexpected rib fractures prompted a comprehensive diagnostic workup, I wanted to understand how doctors connect an isolated ache to an underlying plasma cell disorder. At Joyful Take, we find that clinical acronyms become much less intimidating when you understand the physical mechanisms they describe. Each letter in CRAB represents a distinct biological clue that doctors can measure in routine blood, urine, and imaging tests.

The four hallmarks of the CRAB diagnostic framework

Hematologists created the CRAB system to distinguish benign plasma cell conditions from active multiple myeloma requiring prompt intervention. The four letters track specific organ impacts across the body.

  • C - Calcium elevation (Hypercalcemia): When abnormal plasma cells stimulate osteoclasts to dissolve bone matrix, excess calcium pours into the bloodstream. High calcium levels can cause frequent thirst, nausea, muscle weakness, constipation, and mental fog. Correcting hypercalcemia brings immediate relief.
  • R - Renal insufficiency: Malignant plasma cells produce overwhelming amounts of monoclonal light-chain proteins. As the kidneys filter these proteins, the microscopic tubules can become clogged and inflamed, leading to elevated creatinine levels and reduced kidney function. Early hydration and targeted therapy protect delicate nephrons.
  • A - Anemia: Inside the bone marrow cavity, crowded clusters of myeloma cells take up space that normally belongs to red blood cell precursors. This suppression of healthy erythropoiesis leads to a shortage of oxygen-carrying hemoglobin, causing chronic fatigue, pale skin, and dizziness.
  • B - Bone lesions: Accelerated bone resorption creates osteolytic soft spots, often described as punched-out lesions. These hollowed areas weaken skeletal integrity, making ribs, spine vertebrae, and hips vulnerable to sudden fractures during routine daily tasks.

The laboratory trio that confirms the condition

Spotting one or more CRAB symptoms prompts clinicians to run three confirmatory tests. These diagnostic steps determine whether abnormal plasma cells are present and how actively they are multiplying.

First, doctors perform protein electrophoresis on blood and urine samples. This test separates serum proteins by electrical charge to detect an abnormal monoclonal spike, known as the M-protein. An accompanying serum free light chain assay measures the ratio of kappa to lambda light chains, providing a sensitive measure of clonal activity. These tests identify protein abnormalities even before physical symptoms appear.

Second, advanced imaging maps the skeleton. Modern clinics utilize low-dose whole-body CT scans, PET-CT, or MRI rather than older standard X-rays. These high-resolution scans detect osteolytic bone thinning long before a fracture occurs. They provide a complete structural map of skeletal health.

Third, a bone marrow biopsy provides direct cellular confirmation. A specialist collects a small liquid and core marrow sample from the pelvic bone. Pathologists examine the sample under a microscope to calculate the percentage of plasma cells. A finding of 10 percent or more clonal plasma cells, paired with CRAB features or high-risk biomarkers, establishes a definitive diagnosis.

Core diagnostic tests for multiple myeloma
Test nameSample typeWhat it measures
Serum Protein Electrophoresis (SPEP)BloodMonoclonal M-protein spike concentration
Serum Free Light Chain AssayBloodRatio of unbound kappa to lambda immunoglobulin chains
Low-Dose Whole-Body CTImagingOsteolytic bone lesions and skeletal thinning
Bone Marrow BiopsyBone marrow corePercentage and genetic profile of clonal plasma cells

When we look at modern diagnostic pathways, the value of early detection becomes clear. Catching plasma cell changes through the CRAB criteria gives patients and oncology teams a clear, structured roadmap. Instead of enduring mysterious, persistent aches, patients receive targeted therapies that halt bone resorption, protect kidney health, and restore active vitality. Knowing what each test looks for turns medical uncertainty into purposeful action.

Sources

Every factual claim above traces to one of these. Links open in a new tab.

  1. Multiple Myeloma Diagnosis and StagingMayo Clinic, 2026-04-18.
  2. Plasma Cell Neoplasms Treatment (PDQ)National Cancer Institute, 2026-03-10.
  3. Understanding the CRAB Criteria in MyelomaInternational Myeloma Foundation, 2026-02-14.
  4. Tests for Multiple MyelomaAmerican Cancer Society, 2026-05-01.
  5. Lady A Singer Charles Kelley Announces Cancer Diagnosis: ‘I Feel Really Hopeful’People.com, 2026-09-29.
  6. Understanding Lab Tests and CRAB SymptomsThe Leukemia & Lymphoma Society, 2026-03-12.